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1. CASE PRESENTATION {#ccr32341-sec-0001}
====================

A patient with hypertrophic obstructive cardiomyopathy (HOCM), on sotalol, presented with signs and symptoms of ocular (Figure [1](#ccr32341-fig-0001){ref-type="fig"}) and generalized myasthenia gravis (MG). Neostigmine and repetitive stimulation test was positive. EMG, NCV and antibodies against AChR and MuSK were negative. Work‐ups for thymus, thyroid, and autoimmune disorders were negative. Other neurological differential diagnoses were excluded. Single‐fiber EMG was unavailable. Sotalol was stopped and oral immunosuppressives plus IV IgG started. All neurological findings improved (Figure [S1](#ccr32341-sup-0001){ref-type="supplementary-material"}) during a period of 3 months. Sotalol, a beta blocker, was able to unmask, precipitate, or induce the MG syndrome.[1](#ccr32341-bib-0001){ref-type="ref"}, [2](#ccr32341-bib-0002){ref-type="ref"}
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